CoChat

Postoperative follow‐up of Cushing's disease using cortisol, desmopressin and coupled dexamethasone‐desmopressin tests: a head‐to‐head comparison

Le Marc'hadour, Pauline, Muller, Marie, Albarel, Frederique, Coulon, Anne‐Laure, Morange, Isabelle, Martinie, Monique, Gay, Emmanuel, Graillon, Thomas, Dufour, Henri, Conte‐Devolx, Bernard, Chabre, Olivier, Brue, Thierry, Castinetti, Frederic · 2015 · Clinical Endocrinology
Cited by 25

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Summary: Objective: Predicting the outcome of patients operated on for Cushing's disease (CD) is a challenging task. Our objective was to assess the accuracy of immediate postsurgical plasma cortisol, desmopressin test and the coupled dexamethasone‐desmopressin test (CDDT) as predictors of outcome. Design and patients: Sixty‐seven patients with initial remission and a minimal postsurgical follow‐up greater than 18 months were included in this retrospective bicentre study. Measurements: Follow‐up included 3–6 months followed by yearly 24‐h urinary‐free cortisol, ACTH and cortisol plasmatic levels, a 1‐mg overnight dexamethasone suppression test (1‐mg DST), desmopressin test and the CDDT. ROC curves were performed to define the optimal threshold of immediate postsurgical cortisol level and 3‐ to 6‐month desmopressin test and CDDT, as predictors of final outcome in comparison with classical biological markers of recurrence. Results: Eleven patients presented recurrence. The patient's median follow‐up was 52 months (range, 18–180). As early predictors of outcome, immediate postsurgical plasma cortisol level <35 nmol/l predicted the lack of recurrence with 93% negative predictive value (NPV), whereas predictive positive value (PPV) was 25%. During the follow‐up, the CDDT was more precise than the desmopressin test in predicting the lack of recurrence (100% NPV) when performed in the first 3 years after surgery. Positivity of the CDDT was defined based on ROC curves by ACTH and cortisol increments >50%. The CDDT was highly reproducible, as the same response was observed every year in 91% of the patients. Conclusions: Adding the CDDT the first 3 years after surgery to immediate postsurgical cortisol evaluation should allow obtaining an optimal follow‐up management of patients operated for Cushing's disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cen.12739

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

Metadata

Authors
Le Marc'hadour, P., Muller, M., Albarel, F., Coulon, A., Morange, I., Martinie, M., Gay, E., Graillon, T., Dufour, H., Conte‐Devolx, B., Chabre, O., Brue, T., & Castinetti, F.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2015-03-20
Volume
83
Issue
2
Pages
216-222
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2060866320
Cited by
25
References
9
FWCI
2.03
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.